Screening for lung cancer: A systematic review and meta-analysis
详细信息 查看全文
- 作者：Muhammad Usman Alia ; c ; aliu@mcmaster.ca" class="auth_mail" title="E-mail the corresponding author ; John Millerd ; jmiller@mcmaster.ca" class="auth_mail" title="E-mail the corresponding author ; Leslea Peirsona ; b ; lpeirson@mcmaster.ca" class="auth_mail" title="E-mail the corresponding author ; Donna Fitzpatrick-Lewisa ; b ; fitzd@mcmaster.ca" class="auth_mail" title="E-mail the corresponding author ; Meghan Kennya ; c ; mkenny@mcmaster.ca" class="auth_mail" title="E-mail the corresponding author ; Diana Sherifalia ; b ; dsherif@mcmaster.ca" class="auth_mail" title="E-mail the corresponding author ; Parminder Rainaa ; c ; praina@mcmaster.ca" class="auth_mail" title="E-mail the corresponding author
- 关键词：CTFPHC ; Canadian Task Force on Preventive Health Care ; CXR ; chest radiography ; DANTE ; Detection and Screening of Early Lung Cancer by Novel Imaging Technology and Molecular Essays Trial ; DLCST ; Danish Lung Cancer Screening Trial ; GRADE ; Grading of Recommendations Assessment ; Development and Evaluation ; JHS ; Johns Hopkins Study ; LDCT ; low-dose computed tomography ; LSS ; Lung Screening Study ; KFS ; Kaiser Foundation Study ; MILD ; Multi-centric Italian Lung Detection Trial ; MLP ; Mayo Lung Project ; MSK
- 刊名：Preventive Medicine
- 出版年：2016
- 出版时间：August 2016
- 年：2016
- 卷：89
- 期：Complete
- 页码：301-314
- 全文大小：808 K
文摘
- •
The evidence does not support CXR screening with or without sputum cytology.
- •
LDCT screening significantly reduced lung cancer mortality and overall mortality.
- •
Harms include false positives, major complications & death from invasive testing.
- •
Current evidence warrants the need to develop and improve standardized practices.